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Abstract
Lactobacillus reuteri ATCC 55730 is a probiotic strain that produces, in the
presence of glycerol, reuterin, a broad-spectrum antimicrobial substance. This
strain has been shown to prevent intestinal infections in vivo; however, its
mechanisms of action, and more specifically whether reuterin production occurs
within the intestinal tract, are not known. In this study, the effects of L. reuteri
ATCC 55730 on intestinal microbiota and its capacity to secrete reuterin from
glycerol in a novel in vitro colonic fermentation model were tested. Two reactors
were inoculated with adult immobilized fecal microbiota and the effects of daily
addition of L. reuteri into one of the reactors (c.108 CFUmL1) without or with
glycerol were tested on major bacterial populations and compared with addition of
glycerol or reuterin alone. The addition of glycerol alone or with L. reuteri
increased numbers of the Lactobacillus–Enterococcus group and decreased Escher-
ichia coli. The addition of reuterin significantly and selectively decreased E. coli
without affecting other bacterial populations. The observed decrease in E. coli
concentration during the addition of glycerol (in presence or absence of L. reuteri)
could be due to in situ reuterin production because 1,3-propanediol, a typical
product of glycerol fermentation, was detected during the addition of glycerol.
Introduction
A healthy gastrointestinal tract is colonized by a highly
complex bacterial community, which plays a major role in
human health and nutrition. This bacterial community is
notably involved in the protection of the gastrointestinal
tract by acting as a barrier against colonization by patho-
genic bacteria. Among commensal bacteria, lactobacilli and
bifidobacteria, including those ingested as probiotics have
attracted much attention for their potential to treat or
prevent intestinal infections.
Lactobacillus reuteri ATCC 55730 (also designated as
SD2112) is a well-known obligate heterofermentative pro-
biotic, isolated from human breast milk, and widely used as
a food additive to improve human gastrointestinal health
(Casas & Dobrogosz, 2000). Lactobacillus reuteri ATCC
55730 can survive low pH as it passes through the stomach
to reach the human intestine and colonize it transiently.
Clinical trials have shown that the administration of
L. reuteri ATCC 55730 was associated with therapeutic
effects. It reduces the duration of watery diarrhea caused by
rotavirus or bacteria (Salmonella, Shigella and Campylobacter
species) in children (Weizman et al., 2005), and the occur-
rence of respiratory and gastrointestinal diseases in healthy
adults (Tubelius et al., 2005). Other L. reuteri strains have
also been shown to protect against enteropathogens in mice,
monkeys, chickens and turkeys (Casas & Dobrogosz, 2000).
Different mechanisms have been proposed to account for
the protective action of probiotic bacteria, and more espe-
cially L. reuteri toward enteropathogens, such as stimulation
of the immune system, competition-exclusion, or produc-
tion of antimicrobial compounds such as organic acids or
reuterin. Lactobacillus reuteri is known to produce reuterin
(3-hydroxypropionaldehyde, 3-HPA), a broad-spectrum
antimicrobial substance active in a wide range of pH values
against Gram-positive and Gram-negative bacteria (espe-
cially Escherichia coli), yeasts, fungi, protozoa and viruses
(Vollenweider & Lacroix, 2004). Reuterin production and
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accumulation occur during the anaerobic growth of
L. reuteri in the presence of glycerol and low concentrations
of glucose, under conditions of pH and reduction potential
found in the small and large intestines (Chung et al., 1989).
Indeed, reuterin is believed to provide an ecological compe-
titive advantage to L. reuteri and to be involved in coloniza-
tion resistance against potential pathogens (Edens et al.,
1997). Reuterin synthesis in the colon would occur when
sufficient amounts of glycerol become available as a product
of luminal microbial fermentations, digestion of luminal
fats, sloughed mucus and desquamated epithelial cells, and
intestinal clearing of endogenous plasma glycerol (Casas &
Dobrogosz, 2000). Very little information is available on the
production and/or availability of glycerol for reuterin synth-
esis in the colon. Moreover, reuterin is very difficult to
quantify in vivo due to its aldehyde function that reacts with
amino and sulfhydryl groups readily available in the intes-
tine (Casas & Dobrogosz, 2000).
In this study, the capacity of L. reuteri ATCC 55730 to
produce reuterin from glycerol in a complex bacterial
ecosystem similar to that of the human intestine was tested.
To estimate reuterin production, two specific markers were
analysed: 1,3-propanediol, a typical product of glycerol
fermentation formed from reuterin reduction (Biebl et al.,
1999), and Escherichia coli highly sensitive to reuterin
activity (Rasch, 2002). With this objective, pure reuterin
and L. reuteri ATCC 55730 (in absence or presence of
glycerol) were added in an in vitro model of colonic
fermentation with immobilized fecal microbiota recently
developed and validated (Cinquin et al., 2004, 2006).
Immobilization was shown to preserve bacterial diversity
and induce high cell density in beads and fermentation
effluents as a result of immobilized fecal microbiota growth,
cell release from beads and possibly growth of free cells in
the bulk medium. Moreover, a very high stability renders
this model particularly suitable for long-term fermentation
studies and comparative testing of different conditions with
the same microbiota in the same experiment (Cinquin et al.,
2006).
Materials and methods
Bacterial strain and reuterin production
Lactobacillus reuteri ATCC 55730 was used for reuterin
production and fermentation experiments. It was routinely
cultivated in Mann, Rogosa and Sharpe (MRS) aerobically at
37 1C for 14 h. Reuterin was purified as described by
Vollenweider et al. (2003). The molarity of the reuterin
solution was measured by the assay described for 3-HPA
analysis, based on the colorimetric method of Circle et al.
(1945). Reuterin was stored at 4 1C.
Feces collection and preparation of the
fecal inoculum
A fecal sample (46.5 g) was collected from a healthy,
nonmethanogenic human adult who had not received anti-
biotic therapy for the last 3 months. Promptly after defeca-
tion, the sample was diluted with prewarmed (37 1C)
prereduced (0.05% L-cystein) peptone water (0.1%, pH 7)
to obtain a final fecal concentration of 20% (w/v). The
suspension was then homogenized in a Stomachers (Sew-
ard, Norfolk, UK) for 2min and filtered through a 150 mm
nylon membrane (Sefar AG, Ru¨schlikon, Switzerland) to
remove large particles, under continuous CO2 bubbling.
When about 10mL of the slurry were filtered, the filtrate
was immediately transferred to an anaerobic chamber (Coy
Laboratories, Ann Arbor, MI) with a nitrogen atmosphere
containing 5% (v/v) hydrogen, for immobilization in
polysaccharide beads.
Immobilization technique
The immobilization procedure in 1–2mm polysaccharide
gel beads made of gellan (2.5% w/v) and xanthan gum
(0.25% w/v) was based on a dispersion process in a two-
phase system, as already described (Cinquin et al., 2006).
The entire process was completed in anaerobic conditions
within 1 h.
Culture medium
The culture medium used to simulate adult human ileal
chyme was the same as previously validated by Macfarlane
et al. (1998) with one modification. The reducing agent
(L-cystein) was replaced by titanium (III) citrate (0.6mM)
to avoid binding of L-cystein sulfhydryl groups with reuterin.
A vitamin solution described by Gibson & Wang (1994) and
sterilized by filtration (Minisart 0.2mm, Sartorius,
Go¨ttingen, Germany) was added (0.5mLL1) separately to
the autoclaved (15min, 121 1C) culture medium. Depending
on the test period, this medium was supplemented with
different glycerol concentrations (10 or 100mM) or with
1.3mM of pure reuterin.
Fermentation procedures
Duplicate single-stage reactors based on the model de-
scribed by Cinquin et al. (2004) were used to mimic the
microbial ecosystem of the adult proximal colon. Two
stirred glass reactors with a volume of 300mL (Sixfors,
Infors, Bottmingen, Switzerland) were filled with 210mL
culture medium and 90mL freshly inoculated beads. Batch
fermentations were first carried out for bead colonization
(BC, days 1 and 2). During colonization, the fermented
medium was aseptically replaced by fresh culture medium
every 12 h. Temperature (37 1C) was automatically
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controlled, and pH was maintained at 5.7 by addition of
NaOH at 5M. Anaerobic conditions were maintained dur-
ing the whole fermentation by a continuous flow of pure
CO2 in the headspace.
After bead colonization, each reactor was connected to a
stirred feedstock vessel containing the sterile culture medium
at 4 1C under CO2 atmosphere and to an effluent-receiving
vessel. Continuous feeding and harvesting of medium was
carried out using peristaltic pumps (Reglo analog, Ismatec,
Glattbrugg, Switzerland). Beads were kept in the reactors
using pinched stainless-steel harvesting tubes. The mean
retention time of the medium was set at 25h by adjusting the
feed flow rate to 12mLh1 and the pH was set at 5.7
(Cummings & Macfarlane, 1991). These set points were
chosen to simulate the conditions of the adult proximal colon.
The culture was carried out for a total of 62 days (2 days
of batch culture, plus 60 days of continuous culture) and
was divided into different test periods of 12–24 days (Fig. 1).
The first reactor (R1) was used to test the effects of gly-
cerol addition (final concentration of 10 [10G] or 100
[100G] mM) and purified reuterin (final concentration of
1.3mM) on bacterial populations and metabolic activities,
whereas the second reactor (R2) was used to test the effects
of L. reuteri ATCC 55730 (added daily at a final concentra-
tion of c.108 CFUmL1 into the reactor) in the presence
(final concentration of 10 [Lbr-10G] or 100 [Lbr-100G]
mM) or absence of glycerol (Lbr). Before R2 inoculation,
L. reuteri ATCC 55730 was grown overnight at 37 1C for 14 h
in 200mL MRS broth. The culture was then centrifuged
(10 000 g for 15min at 4 1C) and the pellet resuspended in
10mL (reaching c. 3 1010 CFUmL1) of culture medium.
The cell suspension was then added to the reactor under
continuous mixing. Effluent samples (15mL) were collected
daily from both reactors for plate counts, metabolites
[short-chain fatty acids (SCFA), lactate, glycerol, reuterin
and 1,3-propanediol] and FISH analyses. Sampling of R2
was carried out 5 h after L. reuteri ATCC 55730 introduc-
tion. The pseudo-steady state for each period was reached
when bacterial populations in the reactor effluent did not
change by more than 0.5 log units during 4 consecutive days
(Cinquin et al., 2006).
Bacterial enumeration by plate counts
The concentration of L. reuteri ATCC 55730 in pure culture
was determined by plate counts on MRS agar. Lactobacillus
reuteri ATCC 55730 was recently shown to be resistant to
tetracycline (Kastner et al., 2006). The LAMVAB agar,
selective for isolating lactobacilli in feces (Hartemink et al.,
1997), and Lactobacillus Anaerobic MRS with Vancomycin
and Bromocresol green (LAMVAB) agar supplemented with
tetracycline were used to enumerate total lactobacilli and
L. reuteri ATCC 55730, respectively, in fecal and intestinal
fermentation samples. In a first attempt to selectively
enumerate L. reuteri ATCC 55730, a concentration of
200 mgmL1 tetracycline was added to LAMVAB medium.
This tetracycline concentration was chosen after preliminary
tests with pure cultures of L. reuteri ATCC 55730 and other
Lactobacillus spp. commonly encountered in human feces.
Spiked fecal samples with the same lactobacilli cultures were
also tested (data not shown). Agar plates were incubated in
anaerobic jars at 37 1C for up to 5 days. Results were
expressed as log CFUmL1 of effluent samples. The detec-
tion limit of the method was determined to be log 4.
Bacterial enumeration by FISH
FISH hybridization analyses were performed as described by
Cinquin et al. (2006) on fixed fecal inoculum, fermentation
samples (1.5mL) and beads, from the last 3 days and last day
of each pseudo-steady-state period, respectively. Beads were
dissolved in 1% EDTA solution (pH 7) using a Stomachers
for 5min. Different 50 Cy3-labelled 16S rRNA oligonucleo-
tide probes were used with hybridization conditions specific
for each probe: Bif164 for Bifidobacterium spp. (Langendijk
et al., 1995); Bac303 for Bacteroides–Prevotella cluster (Manz
et al., 1996); Lab158 for Lactobacillus and Enterococcus
(Harmsen et al., 1999); EC1531 for Escherichia coli (Poulsen
et al., 1995); Erec482 for Clostridium coccoides–Eubacterium
rectale group (Franks et al., 1998); and Lbre for Lactobacillus
reuteri (Vogel et al., 1994). For total cell counts 40, 6-
diamidino-2-phenylindole (DAPI) was added at a final
concentration of 1mgmL1. To prevent fading of fluores-
cence, citifluor AF1 (Citifluor Ltd, London, UK) was used.
Cells were counted visually using an Olympus BX 60
epifluorescence microscope (Olympus Schweiz AG, Volkets-
wil, Switzerland) on 10-well slides (Fisher Scientific SA,
Wohlen, Switzerland). To minimize the counting error due
to the radial distribution of bacteria in wells, bacterial
concentrations were calculated from the bacterial density
corresponding to 15 annular regions as already described by
Cinquin et al. (2006). Each assay was carried out in duplicate.
Results were expressed as log cellsmL1 of effluent samples
or g1 of gel beads or feces. The detection limit of the method
was log 6.0 cellsmL1 or g1 of fermentation effluents and
feces, respectively, and log 7.5 cells g1 of gel beads.
Fig. 1. Time schedule of continuous intestinal fermentation experi-
ments during different treatment periods in reactors 1 and 2. BC, bead
colonization; Stab I, stabilization I; Lbr, Lactobacillus reuteri; Lbr-10G, Lb.
reuteri and 10 mM glycerol; Lbr-100G, Lb. reuteri and 100 mM glycerol;
Stab II, stabilization II; 10G, 10 mM glycerol; 100G, 100 mM glycerol.
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Metabolite analyses
SCFA (acetate, propionate, butyrate), lactate, reuterin, gly-
cerol and 1,3-propanediol were determined by HPLC analy-
sis (Hitachi LaChrome, Merck, Dietikon, Switzerland).
Fermentation samples were centrifuged (10 000 g) for
10min at 4 1C, and supernatants were deep-frozen at
 80 1C. Before analysis, samples (1mL) were defrosted,
diluted in ultra pure water (Millipore AG, Volketswil,
Switzerland) and filtered through a 4mm Titan HPLC filter
with a 0.45mm nylon membrane (Infochroma AG, Zug,
Switzerland) directly in vials, which were immediately sealed
and analyzed. The analysis was performed at a flow rate
of 0.4mLmin1 at 25 1C, with 10mM H2SO4 as eluent and
an injection volume of 40 mL. Each analysis was performed
in duplicate. The mean metabolite concentrations were
expressed in millimolar.
Statistical analyses
A one-way ANOVAwas performed using SPSS 13.0 for Windows
(SPSS Inc., Chicago, IL) to test the effects of the different
treatments on bacterial and metabolite concentrations mea-
sured during the pseudo-steady-state periods (mean of 3
successive days) in effluent samples. Treatment means were
compared using the Tukey’s test with the probability level of
Po 0.05. Values in the text are means SD.
Results
Bacterial diversity during the first stabilization
period (Stab I) in both reactors
The mean concentrations of the different bacterial popula-
tions measured by FISH in fecal inoculum, beads and
effluent samples from both reactors at the end of Stab I are
shown in Table 1. Using a fecal inoculum of log 11.2 cells g1,
effluent samples and gel beads were highly colonized with
10.2 log cellsmL1 and 10.7 log cells g1 at the end of Stab I.
Changes in microbial balance were observed in effluent
samples and gel beads compared with the inoculum. Bifido-
bacteria (especially in effluents) and Bacteroides–Prevotella
concentrations decreased and lactobacilli counts (in beads
only) increased. Clostridium coccoides–Eubacterium rectale
remained the dominant group in all samples. All major groups
of intestinal bacteria found in the fecal inoculum were present
in effluent samples and reached stable and similar values for
R1 and R2 after 9 days of fermentation (Table 2).
Effects of glycerol, reuterin and L. reuteri ATCC
55730 on intestinal microbiota composition
In R1, the addition of glycerol did not significantly modify
the main bacterial population counts in the effluent samples
(Table 2), except for the Lactobacillus–Enterococcus group
and E. coli population. Compared with Stab I, the Lactoba-
cillus–Enterococcus group increased significantly by
0.6 log cellsmL1 during 100G. However, no increase in
commensal L. reuteri or in lactobacilli were observed with
the Lbre probe (Table 2) or by selective plating (Fig. 2),
respectively. During 10G and 100G, E. coli decreased by 0.5
and 0.4 log cellsmL1, respectively, compared with Stab I.
This effect was only statistically significant (Po 0.05) for
10G. The same effect was observed during the addition of
reuterin at very low concentrations (1.3mM).
As expected, Lbr, Lbr-10G and Lbr-100G in R2 signifi-
cantly increased Lactobacillus–Enterococcus and L. reuteri
counts compared with Stab I (Table 2). When the addition
of L. reuteri ATCC 55730 was stopped during the second
stabilization period (Stab II), Lactobacillus–Enterococcus and
L. reuteri concentrations returned to previous values mea-
sured during Stab I (Table 2). Similar data were observed
with selective plate counts for total lactobacilli and L. reuteri
ATCC 55730 on LAMVAB and LAMVAB plus tetracycline,
respectively (Fig. 2). Only a fraction of L. reuteri ATCC
55730 could be detected with the Lbre oligonucleotide probe
in pure culture (data not shown). Moreover, only a small
Table 1. Bacterial populations in fecal inoculum, beads and fermentation samples during the first stabilization period of the continuous cultures
measured by FISH
Target organisms Feces Inoculumw Fermentationz Stab I beads‰ PCSz
Total bacteria 10.6–11.6 11.2 0.4 10.2 0.1 10.7 0.2 8.9–10.0
Cl. coccoides–E. rectale 9.9–11.1 10.0 0.3 9.1 0.1 9.1 0.2 9.3–9.5
Escherichia coli 8.0–9.8 9.1 0.3 8.8 0.1 8.9 0.1 7.3
Bifidobacterium spp. 7.2–10.2 9.6 0.3 6.8 0.2 8.6 0.1 o 6.0–9.0
Bacteroides–Prevotella 9.2–10.3 9.2 0.3 7.5 1.0 8.0 0.2 6.8–10.1
Lactobacillus–Enterococcus 8.6–9.5 7.8 0.1 7.5 0.0 8.8 0.2 o 6.0–8.3
Fecal populations (log cells g1) of healthy adults reported in various studies (Franks et al., 1998; Harmsen et al., 1999).
wBacterial concentrations (log cells g1 of feces) are means SD of duplicate analyses of fecal inoculum used in R1 and R2, n = 2.
zBacterial concentrations (log cells mL1) are means SD of effluent samples harvested during the last 3 days of Stab I in R1 and R2, n = 6.
‰Bacterial concentrations (log cells g1 of gel) are means SD of bead samples harvested during the last day of Stab I in R1 and R2, n = 2.
zBacterial populations (log cells mL1) reported for in vitro continuous fermentation samples (PCS, proximal colon simulation) by Bru¨ck et al. (2002),
Probert & Gibson (2004) and Child et al. (2006) (converted from percentage).
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fraction (c.105 CFUmL1) of added L. reuteri ATCC 55730
(Lbr period) was measured with plate counts on selective
LAMVAB medium supplemented with 200 mg tetracycline
(Fig. 2, days 14–29), whereas a large increase of total
lactobacilli, from 6.5 to 8.6 log CFUmL1, was measured on
LAMVAB medium. The strain became apparently more
sensitive to tetracycline in the reactor effluents compared
with the pure culture tested during preliminary experi-
ments. Therefore the concentration of tetracycline was
decreased to 150 mgmL1 for the rest of the fermentation to
improve L. reuteri ATCC 55730 detection (Fig. 2, days
30–60). As already observed during 100G, the E. coli
population selectively and significantly decreased (by
0.5 log cellsmL1) during Lbr-10G and Lbr-100G compared
with Stab I, whereas Lbr did not have any detectable effect
(Table 2). Moreover, when glycerol addition was stopped in
Stab II, bifidobacteria concentrations significantly decreased
by 0.9 log cellsmL1 compared with Lbr-10G and Lbr-100G.
Effects of glycerol, reuterin and L. reuteri ATCC
55730 on metabolic activities
SCFA, glycerol, reuterin and 1,3-propanediol concentrations
were analyzed in fermentation samples from both reactors
for the last 3 days of each treatment period corresponding to
a pseudo-steady state. Total SCFA concentrations ranged
from 146 to 174mM (Table 3) and lactate was only detected
in very small amounts in both reactors (o 0.5mM, data not
shown) for all tested conditions.
In R1, 10G did not affect bacterial metabolism compared
with Stab I. However, an increase in glycerol concentration
during 100G slightly (not significant) decreased the total
SCFA concentration and increased butyrate, while decreas-
ing acetate concentrations. This led to a significant increase
in butyrate (23.6% vs. 31.1%, Po 0.05) and decrease in
acetate (49.3% vs. 44.7%, Po 0.05) ratios in the total SCFA.
The addition of pure reuterin at low concentration
(1.3mM) did not modify the SCFA profile compared with
Stab I, but slightly decreased (Po 0.05) the total SCFA
concentration (Table 3).
Lbr and Lbr-10G in R2 induced a significant increase in total
SCFA concentrations and a modification of SCFA profiles due
to an increase in acetate and propionate and a decrease in
butyrate concentrations compared with Stab I (Table 3).
Compared with Lbr and Lbr-10G, Lbr-100G decreased the
total SCFA concentration due to a considerable decrease in
acetate, while propionate concentration was stable and buty-
rate increased. SCFA concentration and ratios obtained during
Lbr-100G were very similar to those obtained during 100G.
The mean ammonia concentration varied significantly in
both reactors for the different treatments (Table 3). Com-
pared with Stab I, 10G and 100G resulted in a decrease in
Table 2. Bacterial populations measured by FISH in effluent samples from reactors 1 and 2 during pseudo-steady states for different periods of
continuous cultures
Target organisms
Bacterial counts (log cells mL1 medium)
Stab I 10G 100G Reuterin
Reactor 1
Total bacteria 10.30.3a 10.3 0.1a 10.3 0.1a 10.1 0.2a
Cl. coccoides–E. rectale 9.00.1a 9.0 0.1a 8.9 0.2a 8.8 0.1a
Escherichia coli 8.60.2a 8.1 0.2b 8.2 0.1ab 8.0 0.1b
Bifidobacterium spp. 6.70.3a 6.3 0.1a 6.1 0.1a 6.3 0.2a
Bacteroides–Prevotella 7.80.2a 7.6 0.1a 7.6 0.4a 7.4 0.1a
Lactobacillus–Enterococcus 7.40.1a 7.4 0.2a 8.0 0.1b 7.5 0.1a
L. reuteri 6.40.2a 6.4 0.3a 6.5 0.2a 6.2 0.3a
Stab I Lbr Lbr-10G Lbr-100G Stab II
Reactor 2
Total bacteria 10.2 0.1a 10.1 0.1a 10.20.2a 10.2 0.1a 10.2 0.1a
Cl. coccoides–E. rectale 9.0 0.3a 8.5 0.1a 8.60.1a 8.9 0.2a 8.8 0.1a
Escherichia coli 8.8 0.2a 8.9 0.1a 8.30.1b 8.3 0.1b 8.5 0.1a
Bifidobacterium spp. 7.0 0.2ab 6.9 0.1ab 7.40.1a 7.3 0.1a 6.4 0.4b
Bacteroides–Prevotella 7.2 0.1a 7.4 0.1a 7.50.3a 7.5 0.1a 7.6 0.4a
Lactobacillus–Enterococcus 7.5 0.2a 8.5 0.1b 8.30.1b 8.2 0.1b 7.6 0.1a
L. reuteri 6.5 0.1a 7.1 0.2b 7.30.2b 7.3 0.1b 6.8 0.1a
Data are means SD for the last 3 days for each fermentation period in reactors 1 and 2, n = 3. Values with different letters in a row are significantly
different by Tukey’s test, Po 0.05. Stab I, stabilization I; Lbr, L. reuteri; Lbr-10G, L. reuteri and 10 mM glycerol; Lbr-100G, L. reuteri and 100 mM glycerol;
Stab II, stabilization II; 10G, 10 mM glycerol; 100G, 100 mM glycerol.
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ammonia concentration in R1, but this effect was only
significant (Po 0.05) for 100G. During the addition of pure
reuterin, an ammonia concentration similar to 10G and
100G, but significantly lower than in Stab I (Po 0.05) was
measured. In R2, Lbr significantly increased the ammonia
concentration compared with Stab I, but this increase was
reduced during Lbr-10G and Lbr-100G. During Stab II, the
ammonia concentration increased again to reach levels
similar to Lbr.
The glycerol concentration in both reactors remained
under the detection limit of the HPLC method during the
whole fermentation. The concentration of 1,3-propanediol
was also under the detection limit of the method (2mM),
except during 100G and Lbr-100G, which induced a
Fig. 2. Effects of glycerol, Lactobacillus reuteri
ATCC 55730 and reuterin addition on total
lactobacilli (enumerated on LAMVAB agar
plates) and L. reuteri ATCC 55730 (LAMVAB
supplemented with tetracycline at 200 mg mL1
until day 30 and 150 mg mL1 thereafter) popu-
lations during continuous fermentations in reac-
tors 1 and 2: lactobacilli in R1 (––), lactobacilli in
R2 (–’–), L. reuteri ATCC 55730 in R2 (–n–).
Table 3. Concentrations of total SCFA, ammonia, and molar proportions of acetate, propionate and butyrate measured in effluent samples during
different treatments
Fermentation conditions
Stab I 10G 100G Reuterin
(mM) (%) (mM) (%) (mM) (%) (mM) (%)
Reactor 1
Total SCFAw 158.7a 161.9a 153.0a 147.1b
Acetate 79.15.1a 49.8 79.8 3.2a 49.3 68.3 4.9a 44.7 75.42.5a 51.2
Propionate 41.62.3ab 26.2 43.8 1.4ab 27.1 37.0 2.9a 24.2 47.27.5b 32.0
Butyrate 38.0a 3.6a 24.0 38.2 1.1a 23.6 47.6 3.1b 31.1 24.63.4c 16.7
Ammonia 84.4a 74.7ab 70.4b 73.4b
Stab I Lbr Lbr-10G Lbr-100G Stab II
(mM) (%) (mM) (%) (mM) (%) (mM) (%) (mM) (%)
Reactor 2
Total SCFAw 146.3a 173.9b 167.5b 157.1a 157.8ab
Acetate 77.2 3.6ac 52.8 113.8 4.1b 65.4 105.7 0.6b 63.1 74.6 5.0c 47.5 93.8 7.7a 57.7
Propionate 20.9 1.8a 14.2 39.2b 2.5b 22.6 40.8 1.5b 24.3 42.1 3.8b 26.8 44.0 2.9b 27.1
Butyrate 48.3 3.0a 33.0 21.0b 1.2b 12.0 21.1 2.2b 12.6 40.4 6.4a 25.7 24.7 2.2b 15.2
Ammonia 68.0a 94.5b 83.8c 79.1c 93.7b
Data are means SD of the last 3 days of each pseudo-steady-state period in reactors 1 and 2, n = 3. Values with different letters in a row are
significantly different by Tukey’s test, Po 0.05. Stab I, stabilization I; Lbr, L. reuteri; Lbr-10G, L. reuteri and 10 mM glycerol; Lbr-100G, L. reuteri and
100 mM glycerol; Stab II, stabilization II; 10G, 10 mM glycerol; 100G, 100 mM glycerol.
wDefined as the sum of acetate, propionate and butyrate concentrations.
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dramatic increase (Po 0.05) in 1,3-propanediol concentra-
tion to 37.0 4.3 and 15.6 4.2mM for R1 and R2,
respectively (Fig. 3). No reuterin accumulation was detected
in fermentation samples, even during Lbr-100G.
Discussion
In this study, the effects of L. reuteri ATCC 55730 on adult
intestinal microbiota and its capacity to secrete reuterin
under conditions simulating the human proximal colon in
the presence or absence of glycerol using an in vitro colonic
model with immobilized fecal microbiota were investigated.
All bacterial populations tested in the fecal inoculumwere
retrieved in R1 and R2 at the end of Stab I. However, a new
bacterial balance was established, with similar patterns in
both reactors, which differed from that observed in the fecal
inoculum. This type of change in population ratios is
usually observed with in vitro intestinal fermentation sys-
tems (Macfarlane et al., 1998; Cinquin et al., 2006) and
reflects changes due to applied fermentation conditions
(retention time, culture medium, pH), which differ from
conditions previously encountered in the host intestine.
However, the different bacterial concentrations were within
the range of physiological values for healthy adults as well as
for other in vitro colonic fermentation models (Franks et al.,
1998; Probert & Gibson, 2004). Bacterial ecosystems estab-
lished in R1 and R2 were therefore used to test L. reuteri
ATCC 55730 and glycerol effects in the human colon.
The addition of glycerol in R1 (100G) strongly modified
the SCFA ratio (by increasing butyrate) compared with Stab
I. A marked increase in 1,3-propanediol production was also
observed, which could explain the lack of effect of glycerol
addition on SCFA concentration. Glycerol can be metabo-
lized by various bacteria (Lin, 1976), but only a few
enterobacteria (Klebsiella pneumonia, Citrobacter freundii,
Enterobacter agglomerans), lactobacilli (L. reuteri, Lactoba-
cillus brevis, Lactobacillus collinoides and Lactobacillus buch-
neri) and clostridia (Clostridium butyricum, Clostridium
perfringens and Clostridium pasteurianum) are known to
produce 1,3-propanediol from this polyol (Biebl et al.,
1999). Among these propanediol-producers, clostridia
(especially C. butyricum and C. perfringens) are the most
commonly reported intestinal species (Hill et al., 1990),
and contrary to L. reuteri and other propanediol-producers,
they are the only ones known to produce butyrate as a by-
product, together with 1,3-propanediol during glycerol
fermentation (Biebl et al., 1999). The metabolism of
glycerol by commensal C. butyricum and/or C. perfringens
might explain the simultaneous increase in 1,3-propanediol
and butyrate during 100G. However, the bacterial intestinal
ecosystem and the related metabolic pathways are very
complex and many other commensal propanediol-
producers, such as L. reuteri, L. buchneri and L. brevis as
well as nonpropanediol producers, may be involved in the
final metabolic effects of glycerol supplementation because
the metabolism of intestinal bacteria is closely interrelated.
The introduction of L. reuteri ATCC 55730 in R2 (Lbr)
changed the intestinal fermentation pattern compared with
Stab I. The fermentative capacity of the microbiota in-
creased due to a significant increase in propionic and acetic
acids concentrations, while butyric acid decreased and lactic
acid concentration remained low. These metabolic effects
are consistent with the heterofermentative pattern of
L. reuteri, which mainly produces lactic and acetic acids
by the pentose phosphoketolase pathway. The absence of
lactic acid accumulation in the medium was expected
Fig. 3. Concentrations (mM) of 1,3-propanediol in reactor 1 and reactor 2: 1,3-propanediol (–m–) in R1 (without Lactobacillus reuteri ATCC 55730);
1,3-propanediol (–’–) in R 2 (with L. reuteri). Data are means of duplicate analyses.
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because lactic acid is an intermediate metabolite that is
usually used by other intestinal bacteria.
The increase in lactobacilli–enterococci populations dur-
ing 100G in R1 was not due to a stimulation of commensal
L. reuteri because no increase was observed with the Lbre
probe compared with Stab I. As expected, the addition of
L. reuteri ATCC 55730 in R2 (Lbr) resulted in increased
lactobacilli–enterococci population, but had no effects on E.
coli concentration and on the other bacterial populations
tested. However, a specific and significant decrease in E. coli
was observed during Lbr-10G and Lbr-100G. This effect
might be due to reuterin production from glycerol fermen-
tation by L. reuteri ATCC 55730 although reuterin could not
be detected by HPLC in the fermentation samples. Escher-
ichia coli (pathogen and nonpathogen strains) are known to
be very sensitive to reuterin (Axelsson et al., 1989). The
addition of glycerol alone (10G and 100G) or a small
concentration of pure reuterin (1.3mM) also induced a
specific decrease in E. coli population. These data suggest the
production of an inhibitory metabolite that specifically
targets E. coli and has a similar activity to pure reuterin
during intestinal fermentation in the presence of low
(10mM) and high (100mM) glycerol concentrations, with
or without L. reuteri ATCC 55370.
Reuterin is a highly reactive molecule due its aldehyde
function that reacts with amino- or sulfhydryl groups in the
medium or with bacteria (Casas & Dobrogosz, 2000). This
reactivity might explain the lack of detection of reuterin,
even during Lbr-100G. As for sugar fermentation, glycerol
can also be converted to acetate, butyrate, lactate, succinate,
ethanol, n-butanol and 2,3-butanediol and/or reduced to
1,3-propanediol via reuterin production. The accumulation
of 1,3-propanediol, a typical product of glycerol fermenta-
tion not found in anaerobic conversions of other organic
substrates (Biebl et al., 1999), showed that glycerol was
metabolized via the reuterin pathway. Although it is believed
that some strains of L. reuteri are unique among propane-
diol producers in their ability to accumulate reuterin from
glycerol (Casas & Dobrogosz, 2000), few enterobacteria and
C. butyricum can accumulate reuterin during in vitro
fermentation of glycerol (Barbirato et al., 1996; Gonzalez-
Pajuelo et al., 2005). These data suggest that small amounts
of reuterin were produced in R1 during addition of glycerol
by intestinal propanediol-producers such as C. butyricum
or commensal L. reuteri, because small concentrations of
L. reuteri were detected in fermentation samples from R1.
The lower 1,3-propanediol concentration measured during
Lbr-100G in R2 compared with 100G in R1 might be
explained by the fact that L. reuteri ATCC 55730 is much
more effective for producing and accumulating reuterin
compared with other propanediol producers, which mostly
produce reuterin as a transient metabolite that is immedi-
ately reduced to 1,3-propanediol (Casas & Dobrogosz, 2000;
Vollenweider & Lacroix, 2004). In this case, reuterin formed
by L. reuteri ATCC 55730 could rapidly react with amino or
sulfhydryl groups, escaping from the conversion to 1,3-
propanediol. The E. coli population decreased similarly by
0.4–0.6 log cellsmL1 with the addition of pure reuterin
(1.3mM), or glycerol (10G and 100G) in the presence or
absence of L. reuteri ATCC 55730.
These data strongly suggest that the decrease in E. coli
concentrations observed during addition of glycerol (in
presence or absence of L. reuteri ATCC 55730) was due to
in situ reuterin production. A very low reuterin concentra-
tion, and low glycerol concentration were sufficient to
induce a significant reduction in E. coli population whereas
the combination of L. reuteri ATCC 55730 with glycerol did
not improve the effect. The key question is now to deter-
mine how much glycerol (either derived directly from
ingestion, produced by bacterial lipase or fermentation of
desquamed epithelial cells) is readily available in vivo for
bacterial conversion within the human intestine. Further
experiments with more sensitive methods (for example with
14C-enriched glycerol) should also be performed in vitro, as
well as in vivo with animal studies simulating different
human populations (young infants or patients with short-
bowel syndrome) to follow the intestinal metabolism of
glycerol and investigate its effects on bacterial populations,
activity and host health.
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